Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / GENOMIC ADV ETF
-
Total 13F shares
-
30,030
-
Share change
-
-1,551
-
Total reported value
-
$962,000
-
Price per share
-
$32.04
-
Number of holders
-
7
-
Value change
-
-$80,086
-
Number of buys
-
3
-
Number of sells
-
4
Institutional Holders of FRANKLIN TEMPLETON ETF TR - GENOMIC ADV ETF (HELX) as of Q2 2022
As of 30 Jun 2022,
FRANKLIN TEMPLETON ETF TR - GENOMIC ADV ETF (HELX) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,030 shares.
The largest 7 holders included
JANE STREET GROUP, LLC, COMMONWEALTH EQUITY SERVICES, LLC, BENJAMIN F. EDWARDS & COMPANY, INC., UBS Group AG, ADVISOR GROUP HOLDINGS, INC., HARBOUR INVESTMENTS, INC., and PNC Financial Services Group, Inc..
This page lists
7
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.